title: Current perspective - trastuzumab.
abstract: This article will review the available clinical data on the efficacy of trastuzumab in the treatment of both early advanced breast cancer.
authors.affiliation: University of Leeds, UK. p.s.hall@leeds.ac.uk
authors.forename: Peter S
authors.initials: PS
authors.lastname: Hall
authors.forename: David A
authors.initials: DA
authors.lastname: Cameron
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D017024:Chemotherapy, Adjuvant; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D018734:Genes, erbB-2; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000235:genetics; D000068878:Trastuzumab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab